General
Preferred name
TOLMETIN
Synonyms
TOLMETIN SODIUM ()
Tolectin ()
Tolmetin sodium salt dihydrate ()
tolmetin, Gilead ()
Tolmetin (sodium dihydrate) ()
MCN2559 ()
Tolmetin (sodium salt hydrate) ()
Sodium tolmetin ()
Tolmetin sodium dihydrate ()
Tolectin 600 ()
Tolmetin sodium anhydrous ()
McN-2559-21-98 ()
Tolectin DS ()
NSC-757341 ()
Tolmetine ()
MCN-2559 ()
Tolmetina ()
P&D ID
PD009991
CAS
64490-92-2
26171-23-3
35711-34-3
Tags
available
drug
Approved by
FDA
First approval
1976
Drug indication
Arthralgia
Rheumatoid arthritis
Drug Status
approved
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Tolmetin sodium dihydrate is an orally active and potent COX inhibitor with IC50s of 0.35 ¦ÌM and 0.82 ¦ÌM human COX-1 and COX-2, respectively. Tolmetin sodium dihydrate is a non-steroidal anti-inflammatory drug (NSAID)[1][2].
DESCRIPTION
Tolmetin is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic activity.
Marketed formulations may contain tolmetin sodium (PubChem CID 23665411). (GtoPdb)
Marketed formulations may contain tolmetin sodium (PubChem CID 23665411). (GtoPdb)
DESCRIPTION
Tolmetin is an orally active and potent COX inhibitor with IC50s of 0.35 ¦ÌM and 0.82 ¦ÌM human COX-1 and COX-2, respectively. Tolmetin is a non-steroidal anti-inflammatory drug (NSAID)[1][2].
PRICE
29
DESCRIPTION
Tolmetin is a potent COX inhibitor. It is a non-steroidal anti-inflammatory drug (NSAID) and also exhibits analgesic and antipyretic activity.
(Enamine Bioactive Compounds)
DESCRIPTION
Tolmetin (Tolectin) is a Nonsteroidal Anti-inflammatory Drug. The mechanism of action of tolmetin is as a Cyclooxygenase Inhibitor. The chemical classification of tolmetin is Nonsteroidal Anti-inflammatory Compounds.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
25
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine Bioactive Compounds
Enamine BioReference Compounds
Guide to Pharmacology
Ki Database
LSP-MoA library (Laboratory of Systems Pharmacology)
NCATS Inxight Approved Drugs
NPC Screening Collection
Other bioactive compounds
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
66
Molecular Weight
257.11
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
1
Rotatable Bonds
4
Ring Count
2
Aromatic Ring Count
2
cLogP
2.19
TPSA
59.3
Fraction CSP3
0.2
Chiral centers
0.0
Largest ring
6.0
QED
0.85
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
COX
COX-1
COX-2
PTGS1, PTGS2
Immunology & Inflammation related
Indication
rheumatoid arthritis, osteoarthritis
MOA
cyclooxygenase inhibitor
Therapeutic Class
Antiinflammatory Agents
Pathway
Immunology/Inflammation
Neuroscience
Source data

